Product: STENABOLIC SR9009 15MG / PER CAPSULE – 30 CAPSULES
Brand: GENLABS
Category: Research Compounds / Endurance & Metabolic Optimizers
In the pursuit of peak physical performance and metabolic efficiency, the scientific community has long sought agents that can directly influence the body's core regulatory clocks. GENLABS is proud to introduce STENABOLIC SR9009, a premium-grade, meticulously formulated research compound centered on Stenabolic (SR9009), a pioneering Rev-ErbA agonist. This product represents not just another supplement, but a sophisticated tool for studying the profound link between circadian biology, mitochondrial function, and whole-body metabolism.
Designed for the discerning research professional, each capsule delivers a potent 15mg dose of pure SR9009, packaged in a 30-capsule cycle for comprehensive study protocols. GENLABS’ commitment to 99%+ analytical purity, independent third-party verification, and cGMP-compliant manufacturing ensures researchers have access to a reliable, consistent, and uncontaminated compound for their critical investigations into endurance, fat metabolism, and cellular energy.
SR9009, commonly referred to as Stenabolic, is a synthetic compound that functions as a potent and selective agonist of the Rev-ErbA proteins (specifically Rev-ErbAα). To understand its potential, one must first understand these proteins' role.
Rev-ErbA proteins are core components of the body's circadian clock machinery, regulating the expression of genes that control a wide array of metabolic processes. They act as "metabolic brakes" during certain circadian phases. SR9009 binds to and activates these Rev-ErbA receptors, amplifying their natural activity.
This activation triggers a cascade of genetic signaling that ultimately influences:
Mitochondrial Biogenesis: Rev-ErbA agonism is shown to upregulate key genes like *PGC-1α* (Peroxisome proliferator-activated receptor-gamma coactivator 1-alpha), the master regulator of mitochondrial creation. More mitochondria mean a greater cellular capacity for energy (ATP) production.
Lipid Metabolism: It promotes genes involved in fatty acid oxidation (burning fat for fuel) while simultaneously inhibiting genes responsible for lipid storage (lipogenesis).
Glucose Metabolism: Influences pathways that enhance insulin sensitivity and glucose uptake into muscles, optimizing carbohydrate utilization.
Inflammatory Response: Modulates the expression of genes linked to inflammation, contributing to a more efficient recovery environment.
Research on SR9009 points to a multi-faceted impact on physiological systems. Please note: The following are areas of scientific interest based on published preclinical studies. This product is sold for laboratory research use only.
1. Profound Enhancement of Endurance Capacity:
The most striking area of research involves endurance. Studies suggest that by dramatically increasing mitochondrial density in skeletal muscle, SR9009 may significantly boost stamina and exercise capacity. Subjects demonstrated a remarkable increase in running duration and distance without prior training adaptation, pointing to a direct enhancement of the muscle's oxidative, fatigue-resistant (Type I) fibers. For research focused on aerobic performance, SR9009 presents a unique model for studying non-hormonal endurance modulation.
2. Accelerated Fat Loss & Metabolic Rate Optimization:
By shifting the body's preferred fuel source towards lipids and enhancing basal metabolic rate through increased mitochondrial activity, SR9009 is a compound of high interest in metabolic syndrome and body composition research. It appears to promote a leaner physique not by stimulating the central nervous system (like stimulants), but by reprogramming cellular metabolism to be more efficient at utilizing stored fat, even during periods of rest.
3. Improved Lipid Profiles & Cardiovascular Health Markers:
Research indicates that activation of Rev-ErbA by SR9009 can lead to favorable changes in cholesterol and triglyceride levels. It is associated with reducing "bad" LDL cholesterol and triglycerides while maintaining or elevating "good" HDL cholesterol. This makes it a compelling compound for studies on atherosclerosis and cardiovascular metabolic health.
4. Circadian Rhythm Regulation & Inflammation Control:
Given its direct action on circadian clock genes, SR9009 is a valuable tool for researching disorders of metabolism linked to circadian misalignment (e.g., shift work disorders). Its anti-inflammatory effects, mediated through Rev-ErbA's suppression of pro-inflammatory gene pathways, are also a significant area of scientific inquiry for recovery and systemic health.
In a market rife with inconsistency, GENLABS sets the standard for research-grade quality.
Unmatched Purity & Potency: Every batch is synthesized to exceed 99% purity, confirmed via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). What you see on the label—15mg of active SR9009—is precisely what is in each capsule.
Independent Third-Party Lab Verified: We go beyond in-house testing. Our CoAs (Certificates of Analysis) are provided by accredited, unbiased third-party laboratories, guaranteeing verifiable purity and the absence of harmful solvents, heavy metals, or microbiological contaminants.
cGMP-Certified Manufacturing: Our products are manufactured in facilities that adhere to current Good Manufacturing Practices (cGMP), ensuring strict hygiene, procedural, and quality control protocols from raw material to finished capsule.
Precise Dosage in Convenient Capsules: The 15mg dosage aligns with common research protocols found in scientific literature. The pre-dosed capsules eliminate measuring errors, ensuring accurate and consistent administration in study settings.
Transparency & Professionalism: GENLABS provides full disclosure of ingredients (vegan-friendly capsules, no unnecessary fillers) and accessible batch-specific CoAs. We cater to professional researchers who require documentation as much as they require the product itself.
Compound: SR9009 (Stenabolic)
Concentration: 15mg per capsule
Contents: 30 capsules per bottle
Form: Oral Capsule
Recommended Research Cycle (Based on Literature): A typical research cycle in preclinical models often involves a daily dosage split into 2-3 administrations due to the compound's estimated half-life of 4-6 hours. A common total daily research dosage ranges from 20-30mg. Therefore, one 30-capsule bottle (15mg/capsule) may support a study duration of approximately 10-15 days, depending on the specific protocol design. Researchers must determine their own dosing schedules based on their specific model and objectives.
Handling: Store in a cool, dry place away from direct sunlight. Stable at room temperature.
GENLABS is dedicated to empowering the scientific community with the highest quality research compounds. We understand that the integrity of your results depends on the integrity of your materials. With STENABOLIC SR9009, you are not just purchasing a compound; you are investing in a reliable, documented, and potent tool to explore the frontiers of metabolism, endurance, and circadian biology.
Disclaimer: GENLABS STENABOLIC SR9009 is intended for laboratory research use only, in vitro studies, or for use in certified preclinical research models under the guidance of qualified professionals. It is not for human consumption, not a dietary supplement, and not intended to diagnose, treat, cure, or prevent any disease. This product must be handled by trained individuals adhering to appropriate laboratory safety protocols. By purchasing this product, the buyer acknowledges and agrees that they are solely responsible for its lawful and compliant use.
On all orders is set at $25.00
Protected by Bitcoin
On all huge orders